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The leukodystrophies are a heterogeneous group of diseases, which primarily 
affect white matter. An integrated description of the clinical, neuroimaging and 
pathophysiological features is crucial for categorizing these disorders. A group of 
leukoencephalopathies are associated with calcifications. In this article, we review 
these disorders briefly. 
Aicardi-Goutieres Syndrome: Aicardi-Goutieres syndrome (AGS) is a genetically 
heterogeneous autosomal recessive group of encephalopathies with 5 subtypes. 
Classic AGS is characterized by cerebral atrophy, white matter abnormalities, 
intracranial calcifications, chronic CSF lymphocytosis, and elevated CSF alpha-
interferon. Broadly speaking, 2 clinical presentations have been delineated: an early 
onset neonatal form, highly reminiscent of congenital infection seen particularly 
with TREX1 mutations, and a later-onset presentation, sometimes occurring after 
several months of normal development and occasionally associated with remarkably 
preserved neurologic function. Severe neurologic dysfunction becomes clinically 
apparent in infancy, and manifests as progressive microcephaly, spasticity, dystonic 
posturing, profound psychomotor retardation, and often death in early childhood. 
Outside the nervous system, thrombocytopenia, hepatosplenomegaly, and elevated 
hepatic transaminases along with intermittent fever may also erroneously suggest an 
infective process. It is important to exclude of pre-/perinatal infections, in particular 
the TORCH complex. Genetic screening for mutations in the four genes known to 
cause AGS allows definitive confirmation of the diagnosis in the majority (83%).
Cockayne ‘s syndrome: Cockayne syndrome is an autosomal recessive disease due 
to a DNA repair defect. Patients show psychomotor developmental delay, dwarfism, 
progeroid appearance, microcephaly, deafness, pigmentary retinal degeneration, 
optic atrophy, and photosensitivity. Abnormal peripheral nerve conduction is due 
to a demyelinating polyneuropathy. Neuroimaging shows brain atrophy of variable 
degree, namely in brainstem and cerebellum; abnormally high signal intensity on 
T2-weighted images throughout the hemispherical white matter; late involvement 
of the subcortical fibers; abnormal hyperintensity on T1-weighted images in the 
basal ganglia corresponding to calcification.
Cystic leukoencephalopathy without megalencephaly (RNASET 2-deficient 
cystic leukoencephalopathy): It is caused by homozygous or compound 
heterozygous mutation in the RNASET2 gene on chromosome 6q27. Neurologic 
deficits were noted within the first months of life, and included severe intellectual 
impairment, motor retardation, and spasticity. Brain MRI showed extensive cysts 
within the anterior temporal lobes, ventricular enlargement, and white matter 
disease. The signal intensities of the cysts were identical to those of cerebrospinal 
fluid. CT scans showed intracranial calcifications in some subjects. 
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connective tissue. In the fourth decade, patients 
developed neuropsychiatric symptoms, including 
memory impairment, euphoria, loss of social inhibitions, 
and impotency or frigidity. Neurologic examination 
showed exaggerated deep tendon reflexes, pathologic 
reflexes, and dysplasia. Patients usually die between 
ages 35 and 45, and the later features of the disorder 
resemble those of Alzheimer disease. 
Globoid Cell Leukodystrophy (Krabbe Disease): The 
manifestations of Krabbe disease are due to accumulation 
of galactocerebrosides and galactosylsphingosine, 
which in turn leads to loss of oligodendrocytes. Infantile 
Krabbe disease presents in the first 6 months of life as 
hyperirritability, increased muscular tone, fever, and 
developmental arrest. As the disease progresses, there 
is further cognitive decline, myoclonus, opisthotonus, 
nystagmus, and optic atrophy. Patients diagnosed in 
infancy rarely survive beyond 2 years. In an estimated 
10% of cases, symptoms begin after the patient has 
begun to walk; these are considered “late-onset.”  Central 
motor signs include spasticity, ataxia, and weakness. Of 
late-onset patients, 20% have abnormal peripheral nerve 
conduction studies with uniform slowing of conduction 
velocities.
Demyelination of the deep WM, progressively involving 
the subcortical white matter. Calcifications within the 
thalami, basal ganglia, and corona radiata shown by CT 
scan.
Cerebrotendinous xanthomatosis: Also called 
cerebral cholesterosis, is an autosomal recessive form 
of xanthomatosis. it is characterized by progressive 
cerebellar ataxia beginning after puberty and by juvenile 
cataracts, juvenile or infantile onset chronic diarrhea, 
childhood neurological deficit, and tendineous or 
tuberous xanthomas. The initial clinical manifestation 
may be neonatal cholestasis or chronic diarrhea from 
infancy. In 75% of cases, cataract is the first finding, 
often appearing in childhood. Pyramidal signs and/or 
cerebellar ataxia are present in the 20s or 30s. Patients 
may experience extrapyramidal manifestations (dystonia 
and atypical parkinsonism), and peripheral neuropathy. 
MRI shows bilateral hyperintensity of the dentate nuclei 
and cerebral and cerebellar white matter.  
Leukoencephalopathy with calcifications and cysts: 
Triad of leukoencephalopathy, cerebral calcifications 
and cysts (LCC) is a recently reported rare disease 
named ‘Labrune syndrome’. The clinical presentation 
is insidious and variable. Typically, initial symptoms 
are of raised intracranial pressure, later followed 
by focal neurologic deficits resulting in spasticity, 
dystonia, seizures, and cognitive decline. Cerebroretinal 
microangiopathy with calcifications and cysts, an 
autosomal recessive disorder caused by mutation in the 
CTC1 gene that shows phenotypic similarities to Labrune 
syndrome. CRMCC includes the neurologic findings of 
intracranial calcifications, leukodystrophy, and brain 
cysts, but also includes retinal vascular abnormalities 
and other systemic manifestations, such as osteopenia 
with poor bone healing, a high risk of gastrointestinal 
bleeding, hair, skin, and nail changes, and anemia and 
thrombocytopenia. Although Coats plus syndrome 
and Labrune syndrome were initially thought to be 
manifestations of the same disorder, namely CRMCC, 
molecular evidence has excluded mutations in the CTC1 
gene in patients with Labrune syndrome, suggesting that 
the 2 disorders are not allelic.
Naku-Hakola’s disease: Affected patients had onset in 
the third decade of pain and swelling following strain 
of the wrist or ankle; fractures occurred after minor 
accidents. Radiographs showed cystic rarefactions in the 
epiphyseal regions of bones. The cysts contained jelly-
like material and microscopically showed membranous 
and lamellar structures between fatty and collagenous 
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